The expanding role of IL-7 and thymic stromal lymphopoietin as therapeutic target for rheumatoid arthritis

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 5, 2014, Pages 581-594

  Pathak, Kamla ^a  

^a NH 2   (India)

Author keywords

IL 7; Rheumatoid arthritis; Therapeutic target; Thymic stromal lymphopoietin

Indexed keywords

ABATACEPT; ADALIMUMAB; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RITUXIMAB; STAT3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; CRLF2 PROTEIN, HUMAN; IL7 PROTEIN, HUMAN; IMMUNOGLOBULIN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN-7, MOUSE; SELENIUM; TSLPR PROTEIN, MOUSE;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; KERATINOCYTE; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; DEFICIENCY; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNOVIAL FLUID;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-7; MACROPHAGES; MICE; MICE, KNOCKOUT; MOLECULAR TARGETED THERAPY; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-7; SELENIUM; SYNOVIAL FLUID;

EID: 84906329847     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.893295     Document Type: Review

References (103)

1. Sharma P, Pathak K. Are biological targets the final goal for rheumatoid arthritis therapy? Expert Opin Biol Ther 2012;12:1611-22
2. Choy EH, Pitzalis C, Cauli A, et al. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 1996;39:52-6
3. Yudoh K, Matsuno H, Nakazawa F, et al. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000;43:617-27
4. Giliani S, Mori L, DeSaint BG, et al. Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: Cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 2005;203:110-26
5. van Roon JA, Verweij MC, Wenting-Van WM, et al. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4+ T cells and macrophages. Arthritis Rheum 2005;52:1700-10
6. Bingham CO III, Abramson SA. Mechanisms of inflammation. In: Tannenbaum H, Russell AS, editors, Mechanisms in rheumatology. Core Health Services, Toronto; 2001
7. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor-Alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10
8. van Roon JA, Lafeber FP, Bijlsma JW. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum 2001;44:3-12
9. Nawroth PP, Bank I, Handley D, et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986;163:1363-75
10. Arend WP. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: The role of interleukin-1 receptor antagonist. Semin Arthritis Rheum 2001;30(Suppl 2):1-6
11. Miyamoto T, Mori T, Yoshimyra A, et al. STAT3 is critical to promote inflammatory cytokines and RANKL expression in inflammatory arthritis. Arthiritis Res Ther 2012;14(Suppl 1):P43
12. McElroy CA, Dohm JA, Walsh ST. Structural and biophysical studies of the human IL-7/IL-7Ralpha complex. Structure 2009;17:54-65
13. Goodwin RG, Lupton S, Schmierer A, et al. Human interleukin 7: Molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989;86:302-6
14. Kovanen PE, Leonard WJ. Cytokines and immunodeficiency diseases: Critical roles of the gammac-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 2004;202:67-83
15. Rihl M, Kellner H, Kellner W, et al. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis Rheum 2008;58:3430-5
16. Pandey A, Ozaki K, Baumann H, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000;1:59-64
17. Park LS, Martin U, Garka K, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000;192:659-70
18. Hartgring SA, Bijlsma JW, Lafeber FP, et al. Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis 2006;65(Suppl 3):iii69-74
19. van Roon JA, Glaudemans CA, Bijlsma JW, et al. Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients. Arthritis Res Ther 2003;5:R269-76
20. Alderson MR, Tough TW, Ziegler SF, et al. Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 1991;173:923-30
21. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001;7:73-9
22. Damas JK, Waehre T, Yndestad A, et al. Interleukin-7-mediated inflammation in unstable angina: Possible role of chemokines and platelets. Circulation 2003;107:2670-6
23. Unsinger J, McGlynn M, Kasten KR, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010;184:3768-3779
24. Roth J, De Souza GEP. Fever induction pathways: Evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 2001;34(3):301-14
25. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nature Rev Immunol 2011;11:330-42
26. Ziegler SF, Tough TW, Franklin TL, et al. Induction of macrophage inflammatory protein-1beta gene expression in human monocytes by lipopolysaccharide and IL-7. J Immunol 1991;147:2234-9
27. Hartgring SAY, van Roon JAG, Wenting-Van Wijk MW, et al. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum 2009;60:2595-605
28. Sawa S, Kamimura D, Jin GH, et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 2006;203:1459-70
29. van Roon JAG, van Rossum S, Jacobs KM, et al. Maturation of functional antigen presenting cells is inhibited by IL-7 blockade. Arthritis Rheum 2006;54:S598-8
30. van Amelsfort JM, van Roon JA, Noordegraaf M, et al. Proinflammatory mediator-induced reversal of CD4+, CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007;56:732-42
31. Fry TJ, Mackall CL. Interleukin-7: From bench to clinic. Blood 2002;99:3892-904
32. Puel A, Leonard WJ. IL-7Ralpha-dependent signaling is required for T-cell development; basis for T-B+NK+ SCID in humans. Immunol Allergy Clin 2000;20:51-63
33. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003;3:269-79
34. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203:1701-11
35. Goodwin RG, Lupton S, Schmierer A, et al. Human interleukin 7: Molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989;86:302-6
36. Giliani S, Mori L, de Saint BG, et al. Interleukin-7 receptor alpha (IL-7R alpha) deficiency: Cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 2005;203:110-26
37. Chou YK, Bourdette DN, Barnes D, et al. IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains. J Neuroimmunol 1999;96:101-11
38. Lum JJ, Schnepple DJ, Nie Z, et al. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 2004;78:6033-42
39. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995;154:5093-102
40. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008;205:1701-14
41. Van Roon JA, Lafeber FP. Role of interleukin-7 in degenerative and inflammatory joint diseases. Arthritis Res Ther 2008;10:107
42. Leistad L, Ostensen M, Faxvaag A. Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction. Scand J Rheumatol 1998;27:61-7
43. Standiford TJ, Strieter RM, Allen RM, et al. IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. J Immunol 1992;149:2035-9
44. Girard D, Beaulieu AD. Absence of the IL-7 receptor component CDw127 indicates that gamma(c) expression alone is insufficient for IL-7 to modulate human neutrophil responses. Clin Immunol Immunopathol 1997;83:264-71
45. Colucci S, Brunetti G, Cantatore F, et al. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 2007;212:47-55
46. Sawa S, Kamimura D, Jin GH, et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 2006;203:1459-70
47. van Roon JA, Hartgring SA, Wenting-Van WM, et al. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:664-9
48. Pickens SA, Chamberlain ND, Volin MV, et al. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2011;63:2884-93
49. Cope AP, Londei M, Chu NR, et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 1994;94:749-60
50. Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997;94:9360-5
51. Toraldo G, Roggia C, Qian WP, et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 2003;100:125-30
52. Long IL7 is demonstrated to induce production of matrix metallo proteinase-13 (MMP-13
53. De Benedetti F, Massa M, Pignatti P, et al. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol 1995;22:1581-5
54. Churchman SM, Ponchel F. Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) 2008;47:753-9
55. Girard D, Beaulieu AD. Absence of the IL-7 receptor component CDw127 indicates that gamma(c) expression alone is insufficient for IL-7 to modulate human neutrophil responses. Clin Immunol Immunopathol 1997;83:264-71
56. van Amelsfort JM, van Roon JA, Noordegraaf M, et al. Proinflammatory mediator-induced reversal of CD4+, CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007;56:732-42
57. Hartgring SA, Willis CR, Alcorn D, et al. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 2010;62:2716-25
58. Park LS, Martin U, Garka K, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000;192:659-70
59. Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007;204:253-8
60. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-80
61. Ying S, O'Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-Attracting chemokines and disease severity. J Immunol 2005;174:8183-90
62. Kato A, Favoreto S Jr, Avila PC, et al. TLR3-And Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007;179:1080-7
63. Moon PD, Kim H. The suppression of thymic stromal lymphopoietin expression by selenium. Amino Acids 2012;43:999-1004
64. Moon PD, Choi IH, Kim H. Berberine inhibits production of thymic stromal lymphopoietin by the blockade of caspase1 NF-kappaB pathway in mast cells. J Immunopharmacol 2011;11:1954-9
65. Moon PD, Choi IH, Kim H. Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase1 NF-kappaB pathway in mast cells. Amino Acids 2012;42:2513-19
66. Moon PD, Choi IH, Kim H. Naringenin inhibits the production of thymic stromal lymphopoietin by the blockade of RIP2 and caspase1 cascade signals in mast cells. Eur J Pharmacol 2011;671:128-32
67. Lee HC, Headley MB, Iseki M, et al. Cutting edge: Inhibition of NF-kappaB-mediated TSLP expression by retinoid X receptor. J Immunol 2008;181:5189-93
68. Quentmeier H, Drexler HG, Fleckenstein D, et al. Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Leukemia 2001;15(8):1286-92
69. Park LS, Martin U, Sims JE. Cloning of the murine thymic stromal lymphopoietin (Tslp) receptor. J Exp Med 2000;192:659-70
70. He R, Geha RS. Thymic stromal lymphopoietin. Ann NY Acad Sci 2010;1183:13-24
71. Al-Shami A, Spolski R, Kelly J, et al. A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 2004;200:159-68
72. Puel A, Ziegler SF, Buckley RH, et al. Defective IL7R expression in T(-)B(+) NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-7
73. Liu YJ, Soumelis V, Watanabe N, et al. TSLP: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Ann Rev Immunol 2007;25:193-219
74. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-14
75. Rochman Y, Leonard WJ. Thymic stromal lymphopoietin: A new cytokine in asthma. Curr Opin Pharmacol 2008;8:249-54
76. Yokoi T, Amakawa R, Tanijiri T, et al. Mycobacterium bovis bacillus calmette-guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-Activated dendritic cells. Int Immunol 2008;20:1321-9
77. Watanabe N, Hanabuchi S, Marloie-Provost MA, et al. Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential. Blood 2005;105:4749-51
78. Reche PA, Soumelis V, Gorman DM, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001;167:336-43
79. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996;39:115-24
80. Koyama K, Ozawa T, Hatsushika K, et al. A possible role for TSLP in inflammatory arthritis. Biochem Biophys Res Commun 2007;357:99-104
81. Ozawa T, Koyama K, Ando T, et al. Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone. Mod Rheumatol 2007;17:459-63
82. Kimura MY, Pobezinsky LA, Guinter TI, et al. IL-7 signaling must be intermittent, not continuous, during CD8+ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol 2013;14:143-51
83. Iolyeva M, Aebischer D, Proulx ST, et al. Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage. Blood 2013;122:2271-81
84. Vandergeeten C, Fromentin R, DaFonseca S, et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood 2013;121(21):4321-9
85. Introini A, Vanpouille C, Lisco A, et al. Interleukin-7 facilitates HIV-1 transmission to cervico-Vaginal tissue ex vivo. PLoS Pathog 2013;9:e1003148
86. Sammicheli S, Ruffin N, Lantto R, et al. IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells. J Autoimmun 2012;38:304-14
87. Perales MA, Goldberg JD, Yuan J. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood 2012;120:4882-91
88. Onder L, Narang P, Scandella E, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood 2012;120(24):4675-83
89. Venet F, Foray AP, Villars-Mèchin A. IL-7 restores lymphocyte functions in septic patients. J Immunol 2012;189:5073-81
90. Lee LF, Logronio K, Tu GH. Anti-IL-7 receptor-Alpha reverses established type 1 diabetes in non-obese diabetic mice by modulating effector T-cell function. Proc Natl Acad Sci USA 2012;109:12674-9
91. Shalapour S, Deiser K, Kühl AA, et al. Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis. PLoS One 2012;7:e31939
92. Pellegrini M, Calzascia T, Toe JG, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011;144(4):601-13
93. Hodge N, Srinivasula S, Hu Z, et al. Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance. Blood 2011;118:3244-53
94. Liu X, Leung S, Wang C, et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 2010;16:191-7
95. Repass JF, Laurent MN, Carter C, et al. IL7-hCD25 and IL7-Cre BAC transgenic mouse lines: New tools for analysis of IL-7 expressing cells. Genesis 2009;47:281-7
96. Sereti I, Dunham RM, Spritzler J, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009;113:6304-14
97. Christmann RB, Mathes A, Affandi AJ, et al. Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor beta. Arthritis Rheum 2013;65:1335-46
98. Moret FM, Radstake TRDJ, Bijlsma JWJ, et al. Abatacept efficacy is overruled by il-7 in tslp-primed myeloid dendritic cell driven t cell activation from rheumatoid arthritis patients Arthritis Rheumatism 65 October 2013 Abstract Supplement Abstracts of the 2013 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; 25-30 October 2013; San Diego, CA
99. Moret FM, Hack CE, Radstake TRDJ, et al. Increased TSLP Expression in joints of rheumatoid Aathritis patients causes increased activation of intraarticular myeloid dendritic cells with enhanced Th1 and Th17 cell activity. Arthritis & Rheumatism, Volume 64, November 2012 Abstract Supplement abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting; 9-14 November 2012; Washington, DC
100. Jeong H-J, Nam S-Y, Oh H-A, et al. Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther 2012;14:R259
101. Roan F, Bell BD, Stollasek TA, et al. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukocyte Biol 2012;91:877-86
102. Hartgring SA, Willis CR, Dean CE Jr, et al. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum 2011;63:1878-87
103. Wu T, Wang J, Jia L, et al. Thymic stromal lymphopoietin: Next research hotspot of carcinogenesiš Adv Biosci Biotech 2012;3:665-8